A viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: a randomized Phase I trial. (nature.com)

Authors: Ottensmeier C … Le Tourneau C Journal: Nature Communications Published: 2026-08-17 DOI: https://doi.org/10.1038/s41467-026-76667-1